Sichuan Huiyu Pharmaceutical Co., Ltd.
SSE:688553.SS
16.09 (CNY) • At close June 6, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Omzet
| 1,094.382 | 927.075 | 1,493.268 | 1,823.733 | 1,364.197 | 707.076 | 54.32 | 13.984 |
| Kosten van de omzet
| 181.511 | 132.753 | 176.182 | 157.299 | 111.828 | 48.292 | 11.16 | 12.273 |
| Brutowinst
| 912.871 | 794.322 | 1,317.086 | 1,666.435 | 1,252.37 | 658.784 | 43.16 | 1.711 |
| Brutowinstmarge
| 0.834 | 0.857 | 0.882 | 0.914 | 0.918 | 0.932 | 0.795 | 0.122 |
| Onderzoek- en ontwikkelingskosten
| 327.725 | 340.758 | 356.194 | 248.212 | 88.774 | 55.615 | 39.15 | 22.142 |
| Algemene en administratieve kosten
| 24.134 | 24.124 | 22.473 | 30.11 | 18.621 | 27.22 | 5.649 | 4.651 |
| Verkoop- en marketingkosten
| 388.649 | 326.942 | 739.055 | 900.755 | 713.141 | 338.129 | 29.621 | 4.177 |
| Verkoop-, algemene en administratieve kosten
| 412.783 | 351.065 | 761.528 | 930.866 | 731.762 | 365.349 | 35.271 | 8.828 |
| Overige kosten
| -176.07 | -21.87 | 44.403 | 25.742 | 40.296 | 25.353 | -0.756 | -0.442 |
| Bedrijfskosten
| 564.438 | 669.953 | 1,162.125 | 1,204.819 | 860.832 | 446.318 | 86.822 | 50.802 |
| Bedrijfsresultaat
| 348.432 | 124.368 | 235.448 | 478.755 | 398.002 | 199.86 | -70.575 | -84.276 |
| Bedrijfsresultaat ratio
| 0.318 | 0.134 | 0.158 | 0.263 | 0.292 | 0.283 | -1.299 | -6.027 |
| Totaal overige inkomsten en kosten netto
| 1.266 | 7.786 | 2.943 | -1.056 | -1.545 | 0.304 | -0.756 | -0.442 |
| Inkomen voor belasting
| 349.699 | 132.154 | 238.391 | 477.7 | 396.457 | 200.164 | -71.331 | -84.718 |
| Inkomen voor belasting ratio
| 0.32 | 0.143 | 0.16 | 0.262 | 0.291 | 0.283 | -1.313 | -6.058 |
| Belastingkosten
| 33.802 | -7.18 | -10.599 | 31.841 | 54.633 | 23.254 | -49.326 | -0.548 |
| Nettowinst
| 325.39 | 139.786 | 248.991 | 445.859 | 343.324 | 176.944 | -22.005 | -84.718 |
| Nettowinstmarge
| 0.297 | 0.151 | 0.167 | 0.244 | 0.252 | 0.25 | -0.405 | -6.058 |
| WPA (Winst Per Aandeel)
| 0.77 | 0.33 | 0.59 | 1.05 | 0.81 | 0.42 | -0.061 | -0.23 |
| Verwaterde WPA
| 0.77 | 0.33 | 0.59 | 1.05 | 0.81 | 0.42 | -0.061 | -0.23 |
| EBITDA
| 441.94 | 203.496 | 292.685 | 519.891 | 423.218 | 233.093 | -24.309 | -23.967 |
| EBITDA ratio
| 0.404 | 0.22 | 0.196 | 0.285 | 0.31 | 0.33 | -0.448 | -1.714 |